Optimizing HIV prevention for people who inject drugs using a checklist
SIRI Checklist: An Integrated Hospital Model to Optimize HIV Prevention in Persons Who Inject Drugs
NA · University of Alabama at Birmingham · NCT05480956
This study is testing a new checklist to see if it can help improve HIV prevention and treatment for people who inject drugs in rural areas.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Alabama at Birmingham (other) |
| Locations | 1 site (Birmingham, Alabama) |
| Trial ID | NCT05480956 on ClinicalTrials.gov |
What this trial studies
This study aims to develop and test a SIRI checklist designed to enhance evidence-based treatment for rural individuals who use drugs. It will involve a prospective analysis of 60 hospitalized persons who inject drugs (PWUD) at UAB, assessing their HIV risk behaviors, substance use, and attitudes towards opioid use disorder treatment and HIV prevention. The study will utilize standardized surveys to gather data on infections, PrEP use, and barriers to care, ultimately aiming to improve hospital-based care models for addiction treatment and infection prevention.
Who should consider this trial
Good fit: Ideal candidates for this study are HIV-negative individuals aged 18 and older with opioid use disorder who are hospitalized at UAB.
Not a fit: Patients who are HIV positive or unable to provide informed consent due to acute illness or intoxication will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve HIV prevention and addiction treatment outcomes for rural populations who inject drugs.
How similar studies have performed: Other studies have shown success with similar integrated care approaches, suggesting potential for this model to be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * We will include 60 PWUD with serious injection related infections (SIRI) who are HIV negative, ≥ 18 years old, have opioid use disorder (OUD) and receiving care at UAB Hospital Exclusion Criteria: * We will exclude those unable to provide informed consent due to acute illness or intoxication, those who don't have OUD, and those who are HIV positive in order to inform HIV prevention interventions.
Where this trial is running
Birmingham, Alabama
- University of Alabama at Birmingham — Birmingham, Alabama, United States (RECRUITING)
Study contacts
- Study coordinator: Mariel Parman, MPH
- Email: marielparman@uabmc.edu
- Phone: 205-996-6337
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: HIV Infections, Opioid-Related Disorders, Pre-Exposure Prophylaxis